| 1 | Current status of diagnosis and treatment of bladder cancer in China-Analyses of Chinese Bladder Cancer Consortium database显示文摘Objective:To investigate current status of diagnosis and treatment of bladder cancer in China.Methods:A database was generated by Chinese Bladder Cancer Consortium(CBCC).From January 2007 to December 2012,14,260 cases from 44 CBCC centers were included.Data of diagnosis,treatment and pathology were collected.Results:The average age was 63.5 year-old and most patients were male(84.3%).The most common histologic types were urothelial carcinoma(91.4%),adenocarcinoma(1.8%),and squamous carcinoma(1.9%).According to 1973 and 2004 WHO grading system,42.0%,41.0%,and 17.0% of patients were grade 1,2,and 3,and 16.0%,48.7%,and 35.3% of patients were papillary urothelial neoplasms of low malignant potential,low,and high grade,respectively.Non-muscle invasive bladder cancer(NMIBC)and muscle invasive bladder cancer(MIBC)were 25.2% and 74.1%,respectively(0.8% not clear).Carcinoma in situ was only 2.4%.Most patients were diagnosed by white-light cystoscopy with biopsy(74.3%).Fluorescence and narrow band imaging cystoscopy had additional detection rate of 1.0% and 4.0%,respectively.Diagnostic transurethral resection(TUR)provided detection rate of 16.9%.Most NMIBCs were treated with TUR(89.2%).After initial TUR,2.6%accepted second TUR,and 45.7%,69.9%,and 58.7% accepted immediate,induced,and maintenance chemotherapy instillation,respectively.Most MIBCs were treated with radical cystectomy(RC,59.7%).Laparoscopic RCs were 35.1%,while open RC 63.4%.Extended and standard pelvic lymph node dissection were 7% and 66%,respectively.Three most common urinary diversions were orthotopic neobladder(44%),ileal conduit(31%),and ureterocutaneostomy(23%).Only 2.3% of patients accepted neo-adjuvant chemotherapy and only 18%of T3 and T4 patients accepted adjuvant chemotherapy.Conclusion:Disease characteristics are similar to international reports,while differences of diagnosis and treatment exist.This study can provide evidences for revisions of the guideline on bladder cancer in China. | Kaiwen Li Tianxin Lin 无 Wei Xue Xin Mu Enci Xu Xu Yang Fubao Chen Guangyong Li Lulin Ma Guoliang Wang Chaozhao Liang Haoqiang Shi Ming Li Mao Tang Xueyi Xue Yisong Lv Yaoliang Deng Chengyang Li Zhiwen Chen Xiaozhou Zhou Fengshuo Jin Xudong Liu Jinxin Wei Lei Shi Xin Gou Weiyang He Liqun Zhou Lin Cai Baiye Jin Guanghou Fu Xiangbo Kong Hongyan Sun Ye Tian Lang Feng Tiejun Pan Yiyi Wu Dongwen Wang Hailong Hao Benkang Shi Yaofeng Zhu Qiang Wei Ping Han Changli Wu Dawei Tian Zhangqun Ye Zheng Liu Zhiping Wang Junqiang Tian Lin Qi Minfeng Chen Wei Li Jinchun Qi Gongxian Wang Longlong Fu Zhaolin Sun Guangheng Luo Zhoujun Shen Zhaowei Zhu Jinchun Xing Zhun Wu Dong Wei Xin Chen Yanqun Na Hongfeng Guo Chunxi Wang Zhihua Lu Chuize Kong Yang Liu Jin Yang Jianyun Hu Xin Gao Jielin Li Changjun Yin Pu Li Shan Chen Zhen Du Jiongming Li Yongji Yan Xu Zhang Shuang Huang Fangjian Zhou Zhiling Zhang Yinghao Sun Shuxiong Zeng Song Cen Jiaquan Zhou Hanzhong Li Jin Wen Jian Huang | 2015 | Asian Journal of Urology2015，2，2： | 21 |
| 2 | N_2O decomposition over K/Na-promoted Mg/Zn–Ce–cobalt mixed oxides catalysts显示文摘Three groups of cobalt mixed oxide catalysts(Mg/Zn–Co, Mg/Zn–Ce–C, K/Na–Mg/Zn–Ce–Co)were prepared by sol–gel or impregnation methods. The synergistic effects of transition metal, rare earth metal and alkali metal on cobalt mixed catalysts for nitrous oxide(N2O)decomposing to N2 and O2were investigated. The experimental results revealed that the catalytic activity for N2 O decomposition was promoted as Co2+was replaced partially by Zn2+/Mg2+, moreover, the characterization analysis by XRD and XPS showed that Zn2+/Mg2+replaced Co2+successfully into the spinel structure of Co3O4 and promoted significantly the catalytic activity. Especially, the addition of CeO2 and K2O/Na2O decreased the binding energy and resulted in an increase in the density of the electron cloud around Co and an improvement of the catalytic activity. Of the investigated cobalt mixed catalysts, the best catalytic activity was shown by 2% K–Zn0.5–Ce0.05–Co catalyst. | Jinli Zhang Hui Hu Jie Xu Gaoming Wu Zhaowei Zeng | 2014 | Journal of Environmental Sciences2014，26，7： | 2 |
| 3 | 脂肪移植后脂肪组织的血管和脂肪生成显示文摘背景脂肪移植的主要缺点是临床上不可预测,所以常会导致外科医师和患者对结果不满意。目前,移植组织血管化和重建的机制尚不明确。方法用两种不同的方法(打碎和完整保留)处理大鼠脂肪组织,以明确移植血管生成的方式。将正常大鼠和表达绿色荧光蛋白转基因大鼠的组织进行交叉移植,观察脂肪再生过程中细胞的起源。结果几乎所有新血管的CD31内皮细胞都来源于受体组织。移植组织中新的血管主要通过受体组织中的血管长入形成的,而不是移植组织的内皮细胞重组或受体组织和移植组织血管的重建形成的。血管生成主要依赖于移植的环境。移植后8周,移植的脂肪组织容量仅下降10%,在脂肪形成过程中,主要再生细胞(CD34+)大部分来自受体组织(P〈0.05)。组织的保留在脂肪打碎组中上升73%,在脂肪完整组中上升47.5%。结论脂肪移植的血管生成主要是通过传统的“血管分支”方式,受体组织起到重要的作用。移植组织的保留方式主要涉及到来源于受体组织的CD34’脂肪前体细胞。 | Ziqing Dong Zhangsong Peng Qiang Chang Weiqing Zhan Zhaowei Zeng Shengchang Zhang Feng Lu 叶美辰 高景恒 张晨 袁继龙 | 2015 | 中国美容整形外科杂志2015，26，10： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员